-
-
Finance -
Finance -
Pharma & Human Health -
Pharma & Human Health
Editor’s Choice
Editor's Choice
Ferring Presents Complete Data across Five RBX2660 Trials Demonstrating Consistent and Durable Efficacy in Recurrent C. Difficile Infection
Ferring Pharmaceuticals and Rebiotix, a Ferring Company, today announced final results of an analysis from five prospective trials of its investigational microbiota-based live biotherapeutic, RBX2660, for the reduction of recurrent C. difficile infection (rCDI). The […]
Editor's Choice
Microbes turn back the clock as research discovers their potential to reverse aging in the brain
Research from APC Microbiome Ireland (APC) at University College Cork (UCC) published in the leading international scientific journal Nature Aging introduces a novel approach to reverse aspects of aging-related deterioration in the brain and cognitive function […]
Editor's Choice
Seres Therapeutics, Nestlé Health Science Announce SER-109 Co-Commercialization License Agreement
Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading microbiome therapeutics company, announced today that it has entered into an agreement with Nestlé Health Science to jointly commercialize SER-109, Seres’ investigational oral microbiome therapeutic for recurrent Clostridioides […]
In Case you Missed it:
Pharma & Human Health
Changing requirements for anaerobic culture equipment in microbiome research and product development
Improved growth of certain organisms (now known to be bacteria) in the absence of oxygen was conclusively demonstrated by Louis Pasteur in the 1860s. Catalytic removal of oxygen from the incubation atmosphere, allowing surface growth […]
Pharma & Human Health
L’Oréal Singapore and NTU Singapore set up joint lab hosted by SCELSE for deeper exploration of skin and scalp microbiomes
Nanyang Technological University, Singapore (NTU Singapore) and L’Oréal Singapore today launched a new joint laboratory hosted by the Singapore Centre for Environmental Life Sciences Engineering (SCELSE), to conduct research on the community of bacteria, fungi, […]
Editor's Choice
Ferring Presents Complete Data across Five RBX2660 Trials Demonstrating Consistent and Durable Efficacy in Recurrent C. Difficile Infection
Ferring Pharmaceuticals and Rebiotix, a Ferring Company, today announced final results of an analysis from five prospective trials of its investigational microbiota-based live biotherapeutic, RBX2660, for the reduction of recurrent C. difficile infection (rCDI). The […]
Pharma & Human Health
Clinical Trial Expert Discussion: Study Design for Microbiome Therapies
Human clinical trials within the functional foods and nutraceuticals industry tend to follow a consistent flow, even though aspects of the process are relatively flexible. However, failure to plan & manage a clinical study effectively […]
Pharma & Human Health
Evelo Biosciences Announces Positive Phase 2 Clinical Data with EDP1815 in Psoriasis
Evelo Biosciences, Inc. (Nasdaq:EVLO), a clinical stage biotechnology company developing SINTAX medicines as a new modality of orally delivered treatments for inflammatory disease, today announced positive data from its Phase 2 study evaluating EDP1815 versus […]
